Grok Technologies Llc

GRoK Technologies is a Houston-based company founded to commercialize NASA life science discoveries in 3D biology, tissue engineering, stem cell technology, bioinformatics and regenerative medicine. Our products and services aim to advance biologic and drug research, vaccine development and production, functional protein production, and clinical research and treatment. GRoK’s technologies arise from NASA R&D in microgravity, fluid suspension, and electromagnetism and their effects on human physiology at the cellular and genetic levels. Our technologies are built on the published research and proven discoveries of Thomas J. Goodwin, PhD, former NASA cellular physiologist, pioneer and a leading authority in the areas of 3D biology, tissue engineering, bioelectromagnetic field effects, and synthesized tissue growth. Dr. Goodwin’s work spans 30 years in the field. He is a scientific advisor to GRoK and serves as Honorary President of the European Society for Translational Medicine (EUSTM). The GRoK intellectual property portfolio is supported by eight NASA licenses, granted exclusively to GRoK, covering 17 U.S. patents. The portfolio supports a robust product development and patenting pipeline.